脑部放疗,上午比下午敏感许多!# J1 U! X" R* G4 [1 i
/ H& @6 F7 N, @# O2 v$ I; z2 w7 S1 o( x* o |. o& D: d4 m
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.4 R6 @3 [3 ]: H6 E; g# _
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
" o& N3 u1 b3 d* zRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.6 n n7 c- g7 T
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.$ @+ K6 C" y, u; Q9 h4 N* u3 i
! ]9 K8 |( `& `# e8 L# F/ Y+ T
Abstract
& o: @& @+ R7 N% N5 }9 H4 gBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.4 c. m5 t, ^' P1 Z
& P$ A0 s1 Z$ K e f3 }METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
* i6 |6 P2 W5 u. C( U% ~( o0 `. v0 e$ U0 Y0 ~
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).# [: d7 r# I) d$ L& Z
- }9 J) ?7 r: l3 t [" N
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
% ~% g2 Q3 ]; ?7 C7 I+ R2 I1 J( y7 ]; [$ w$ x
|